| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | -3,6 M € | -70.3% | -2,1 M € | -4.2% | -2,0 M € | +15.0% | -2,4 M € | |
| Equity | -2,6 M € | -372.9% | 965,5 k € | -43.4% | 1,7 M € | -48.4% | 3,3 M € | |
| Gross margin | -3,3 M € | -65.0% | -2,0 M € | -6.6% | -1,9 M € | +18.8% | -2,3 M € | |
| Staff | 0 | 0 | 0 | — | ||||
| Unit no. | Name | Location |
|---|---|---|
| 2310808036 | DeuterOncology | Clos Chanmurly 13, 4000 Liège |
Public limited company · Liège · incorporated on 28/09/2020 · 0,0 ETP
Public limited company en perte sur le dernier exercice. Trésorerie en repli (-74.6 %).
Key indicators
7-day free trial, no credit card required.
Source: Belgian Official Gazette